Table 5.
Sex-stratified Cox proportional hazards regression model with a robust variance estimator for evaluating the risk of death among patients with colon adenocarcinoma who received adjuvant oral or intravenous fluoropyrimidine chemotherapy.
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Adjuvant Treatment | aHR* | 95%CI | P value | Adjuvant Treatment | aHR* | 95%CI | P value |
| IV fluoropyrimidines | 1.00 | IV fluoropyrimidines | 1.00 | ||||
| Oral fluoropyrimidines | 1.44 | 1.24-1.68 | <.0001 | Oral fluoropyrimidines | 1.18 | 0.97-1.42 | .0933 |
*All the aforementioned variables in Table 2 were used in the multivariate analysis. aHR, adjusted hazard ratio.